Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 05/13/2025 at 18:00, 6 months 22 days ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
PRESS RELEASE

published on 05/13/2025 at 18:00, 6 months 22 days ago

THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE RÉELLE TRÈS POSITIVES SOUTENANT L'EFFICACITÉ DE BATTEN-1 DANS LE TRAITEMENT DE LA MALADIE DE BATTEN CLN3
Theranexus et la Fondation Beyond Batten Disease présentent des résultats prometteurs pour le traitement de la maladie de Batten-CLN3 avec le médicament Batten-1 (miglustat). Nouvelle étude en vie réelle montre une préservation de l'acuité visuelle

Theranexus Batten-1 Miglustat Fondation Beyond Batten Disease Traitement CLN3
BRIEF

published on 04/29/2025 at 19:05, 7 months 5 days ago

Theranexus : Bilan Annuel 2024 et Nouvelles Perspectives

Résultats Financiers Partenariats Theranexus Batten-1 Subventions
BRIEF

published on 04/29/2025 at 19:05, 7 months 5 days ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants
PRESS RELEASE

published on 04/29/2025 at 19:00, 7 months 5 days ago

THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Theranexus publie ses résultats annuels 2024, fait le point sur ses activités et clôture sa ligne de financement. Détails sur Batten-1, PickASO, IMASO et partenariat avec Exeltis

Résultats Annuels Theranexus Batten-1 PickASO Exeltis
PRESS RELEASE

published on 04/29/2025 at 19:00, 7 months 5 days ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
BRIEF

published on 03/06/2025 at 18:05, 8 months 29 days ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases
BRIEF

published on 03/06/2025 at 18:05, 8 months 29 days ago

Modification du contrat de liquidité de Theranexus

Contrat De Liquidité AMF PORTZAMPARC Theranexus Maladies Neurologiques Rares
PRESS RELEASE

published on 03/06/2025 at 18:00, 8 months 29 days ago

MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Theranexus annonce une modification de contrat de liquidité afin de se conformer à la réglementation. Retrait de 50 000 euros. Bilan du 31/12/2024 et présentation de la société

Contrat De Liquidité Réglementation Theranexus Neurologie Batten
BRIEF

published on 01/31/2025 at 18:10, 10 months 4 days ago

Bilan semestriel du contrat de liquidité de Theranexus avec Portzamparc

Contrat De Liquidité Bilan Semestriel Transactions PORTZAMPARC Theranexus

Accesswire

Published on 12/05/2025 at 17:15, 13 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 28 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 43 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 43 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 28 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 3 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 18 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 10 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 10 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 17 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 17 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 30 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE